Actual Medicinal Product (AMP) Avelox 400mg tablets (Bayer Plc)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in an airtight (sealed) container. Anecdotal reports of use in MCAs for up to 7 days (low quality evidence). Manufacturer recommends storing in original container.
- Provenance
-
This recommendation is based on the products Avelox 400mg film-coated tablets (Bayer plc) and Moxifloxacin 400mg film-coated tablets (Rivopharm Ltd).
- Generic
- Moxifloxacin
- Formulation
- Moxifloxacin 400mg tablets
-
Moxifloxacin
-
Moxifloxacin 400mg tablets
-
Avelox 400mg tablets (Bayer Plc)
-
-